Article Versions Notes

Passardi A, Scarpi E, Neri E, Parisi E, Ghigi G, Ercolani G, Gardini A, La Barba G, Pagan F, Casadei-Gardini A, et al. Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers 2019, 11, 663. Cancers. 2020; 12(1):178. https://doi.org/10.3390/cancers12010178

Passardi, Alessandro, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, and et al. 2020. "Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers 2019, 11, 663" Cancers 12, no. 1: 178. https://doi.org/10.3390/cancers12010178

Passardi, A., Scarpi, E., Neri, E., Parisi, E., Ghigi, G., Ercolani, G., Gardini, A., La Barba, G., Pagan, F., Casadei-Gardini, A., Valgiusti, M., Ferroni, F., Frassineti, G. L., & Romeo, A. (2020). Erratum: Passardi, A. et al. Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study. Cancers 2019, 11, 663. Cancers, 12(1), 178. https://doi.org/10.3390/cancers12010178